Publication | Closed Access

Triphenyl-sesquineolignan analogues derived from Illicium simonsii Maxim exhibit potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) by disrupting bacterial membranes

Bacterial MembranesMethicillin-resistant Staphylococcus AureusAntibioticsMedicineAntibacterial AgentMicrobiologyAntimicrobial CompoundTriphenyl-sesquineolignan AnaloguesPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance